Empfehlungen der Deutschen Atemwegsliga zur Spirometrie

Criée, Carl-Peter; Berdel, Dietrich; Heise, D.; Kardos, Péter; Köhler, Dieter; Leupold, W.; Magnussen, H; Marek, W.; Merget, R.; Mitfessel, H.; Rolke, M.; Sorichter, Stephan; Worth, W.; Wuthe, H.

doi:10.1055/s-2006-944245

Cited by 38 publications

(21 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Lung function was assessed with spirometry and body plethysmography (Masterlab; Jaeger, Würzburg, Germany) according the recommendations of the German guidelines [29, 30]. The following parameters were examined: vital capacity (VC [litres, % predicted]), residual volume (litres, % predicted), total lung capacity (litres, % predicted), forced expiratory volume in 1 s (FEV 1 [litres, % predicted]), total specific resistance (kPa•s, % predicted), Tiffeneau index (each before and after administration of bronchodilators), and respiratory muscle function (P 0.1 und PI max [kPa]).…”

Section: Study Design and Methodsmentioning

confidence: 99%

Short-Term Effects of a Multimodal 3-Week Inpatient Pulmonary Rehabilitation Programme for Patients with Sarcoidosis: The ProKaSaRe Study

Lingner

Buhr-Schinner²,

Hummel

et al. 2018

Respiration

View full text Add to dashboard Cite

Background: Real-world data on the effects of a multicomponent pulmonary rehabilitation (PR) for patients with sarcoidosis are scarce. Objective: To describe characteristics of patients with sarcoidosis referred for a 3-week inpatient PR, to assess the effects of PR on their quality of life (QoL) and clinical outcomes, and to investigate whether there are specific subgroups who particularly benefit from PR. Methods: Using a prospective multicentre study design, data regarding 6-min walking distance (6MWD), QoL (Saint George’s Respiratory Questionnaire, SGRQ), and the secondary outcomes of dyspnoea and psychological burden (fatigue, anxiety, and depression) were collected. Results: We included 296 patients in the study (average age 49.1 ± 9.7 years, 47% female, average vital capacity 3.5 ± 1.0 L [87.0 ± 20.6 predicted]). The 6MWD improved by the end of the rehabilitation by 39.8 m on average (p < 0.0001; standardised response mean, SRM = 0.61), SGRQ showed significant improvements in all 3 domains, and the total score (p < 0.001) improved by 5.69–8.28 points (SRM 0.46–0.62). For the secondary outcomes, significant improvement (p < 0.001) was seen for all measured parameters, e.g., dyspnoea (modified Medical Research Council Scale, mMRC), fatigue (Fatigue Assessment Scale [FAS]; SRM = –0.71), anxiety and depression (Hospital Anxiety and Depression Scale [HADS]; SRM –0.58/–0.38), and generic QoL (measured by the SF-36 scales of physical and mental health; SRM 0.31/0.55). Conclusions: Our results provide the first documented evidence that PR is a promising complementary therapy option for sarcoidosis patients who remain subjectively symptomatic despite optimised outpatient medical treatment.

show abstract

Section: Study Design and Methodsmentioning

confidence: 99%

Short-Term Effects of a Multimodal 3-Week Inpatient Pulmonary Rehabilitation Programme for Patients with Sarcoidosis: The ProKaSaRe Study

Lingner

Buhr-Schinner²,

Hummel

et al. 2018

Respiration

View full text Add to dashboard Cite

show abstract

“…Good reproducibility can be assumed if the values obtained for maximal expiratory flow cannot be increased any further by intense effort. The agreement of the two best measured values (the highest sum of FVC and FEV 1 ) should be documented within a defined range (the difference between the two best values of FEV 1 and FVC should not exceed 150 mL) (27,28). The result of the forced-expiration test can be depicted as a flow-volume curve (Figure 3a).…”

Section: Spirometrymentioning

confidence: 99%

“…To distinguish it from the FVC, the vital capacity measured in this way is called the inspiratory vital capacity (abbreviated most correctly as IVC, often shortened to VC). In Germany, the FEV1/IVC ratio is referrred to as the Tiffeneau Index or the relative expiratory capacity in one second (27). For practical purposes, the highest measured value of the vital capacity (VC max ) can be used to compute this ratio (29).…”

Section: Prerequisites For Spirometrymentioning

confidence: 99%

The Diagnosis of Chronic Obstructive Pulmonary Disease

Burkhardt

Pankow²

2014

Deutsches Ärzteblatt International

View full text Add to dashboard Cite

show abstract

“…Atemvolumina, die Atemflüsse und die Veränderungen derselben im Verlaufe eines Atemzyklus [15]. Die Kenntnis der Vitalkapazität (VC max oder forcierte VC, FVC) gibt Aufschluss über mögliche Einschränkungen des Gesamtvolumens (= Restriktion).…”

Section: Lungenfunktionsuntersuchung Und Spirometrieunclassified